Hemangiol (Propranolol Oral Suspension) 3.75mg/ml*120ml

Hemangiol (propranolol) oral suspension is a beta-blocker used to treat infantile hemangioma. This 3.75mg/ml strength liquid helps reduce the size of problematic blood vessel growths in babies. Hemangiol provides a convenient way to administer medication for vascular conditions in young children.

Strength

3.75mg/ml*120ml

Manufacturer / TM Owner

Pierre Fabre Medicament Production

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Hemangiol oral suspension is primarily used to treat infantile hemangioma, a type of non-cancerous blood vessel growth that appears in early infancy. Parents often ask 'what is Hemangiol used for' when their child develops raised red marks or lesions. This medication helps shrink these growths and reduce associated symptoms. It is prescribed by healthcare providers for vascular tumors that may cause complications.

Side Effects

Hemangiol works by affecting the blood vessels in hemangiomas, gradually reducing their size and prominence. Users may notice the treated area becoming less red and raised over several weeks of consistent use. The medication is designed for pediatric patients and comes in a liquid form that's easy to administer. Effects vary by individual and may take time to become apparent.

Precautions & Warnings

Hemangiol should only be used under medical supervision for infants with confirmed hemangioma diagnoses. Keep the medication out of reach of children and pets. Store at room temperature away from moisture and heat. Always use the provided dosing syringe for accurate measurement. Report any unusual symptoms to your pediatrician immediately.

Avoid Interactions

Hemangiol may interact with other medications that affect heart rate or blood pressure. Common classes include other beta-blockers, calcium channel blockers, and certain antidepressants. Always inform your doctor about all medications your child is taking. Avoid giving Hemangiol with foods or supplements that may lower blood sugar unexpectedly.

Frequently Asked Questions

Visible effects typically appear within 2-4 weeks of consistent use, though individual responses vary.

Hemangiol is specifically approved for infantile hemangioma and should not be used for other vascular conditions without medical advice.

Give the missed dose as soon as remembered, but skip it if it's almost time for the next scheduled dose.

Hemangiol can be given with or without food, but always follow your pediatrician's specific feeding recommendations.

Store at room temperature between 15-25°C (59-77°F) in the original container, away from light and moisture.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.